Articles published by IN8bio, Inc
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
April 30, 2024
From IN8bio, Inc
Via GlobeNewswire
Tickers
INAB
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
April 16, 2024
From IN8bio, Inc
Via GlobeNewswire
Tickers
INAB
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
April 09, 2024
From IN8bio, Inc
Via GlobeNewswire
Tickers
INAB
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
March 14, 2024
From IN8bio, Inc
Via GlobeNewswire
Tickers
INAB
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.